Organon (OGN) Pension (2023 - 2024)
Organon (OGN) posted quarterly Pension of $77.0 million for Q4 2024, up 1.32% year-over-year from $76.0 million in Q1 2024, and up 1.32% on a QoQ basis from $76.0 million in Q4 2023.
Organon (OGN) Pension (2023 - 2024) Analysis & Trends
Organon (OGN) has reported Pension for 2 consecutive years, with $77.0 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Pension rose 1.32% year-over-year to $77.0 million; the TTM figure through Dec 2024 stood at $77.0 million (up 1.32% YoY), while the FY2024 annual figure was $77.0 million, up 1.32% from the prior year.
- Pension came in at $77.0 million for Q4 2024 at Organon, up from $76.0 million in the prior quarter.
- The five-year high for Pension was $77.0 million in Q4 2024, with the low at $76.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 77.00 Mn |
| Dec 31, 2023 | 76.00 Mn |